Date: 2011-12-19
Type of information:
Product name: DasKloster 0014
Compound:
Therapeutic area:
Action mechanism: DasKloster 0014 is a human peptide, which interferes with pathological inflammation, certain virus infection, fibrosis, and cancer in liver models.
Company: mondoBIOTECH (Switzerland)
Disease: hepatocellular carcinoma
Latest news:
Patents:
Submission of marketing authorization application USA :
Submission of marketing authorization application UE:
Withdrawal of marketing authorization application USA:
Withdrawal of marketing authorization application UE:
US authorization:
UE authorization:
Favourable opinion UE:
Favourable opinion USA:
Orphan status USA: 2011-05-17
Orphan status UE:
Pediatric exclusivit _USA:
Pediatric exclusivity UE: OTC status: Other news:
